Upregulated Tim-3/galectin-9 expressions in acute lung injury  in a murine malarial model.
Malaria is the most relevant parasitic disease worldwide, and severe malaria is characterized by cerebral edema, acute lung injury (ALI), and multiple organ dysfunctions; however, the mechanisms of lung damage need to be better clarified. In this study, we used Kunming outbred mice infected with Plasmodium berghei ANKA (PbANKA) to elucidate the profiles of T cell immunoglobulin and mucin domain-3 (Tim-3) and its ligand galecin-9 (Gal-9) in the development of ALI. Mice were injected intraperitoneally with 10(6) PbANKA-infected red blood cells. The lungs and mediastinal lymph nodes (MLNs) were harvested at days 5, 10, 15, and 20 post infections (p.i.). The grade of lung injury was histopathologically evaluated. Tim-3- and Gal-9-positive cells in the lungs and MLNs were stained by immunohistochemistry, and the messenger RNA (mRNA) expressions of Tim-3, Gal-9, and related cytokines were assessed using quantitative real-time polymerase chain reaction (qRT-PCR). Bronchoalveolar lavage fluid (BALF) analyses were performed from days 18 to 20 p.i. The results showed that the pathological severities in the lungs were increased with times and the total protein level in the BALFs was significantly elevated in PbANKA-infected mice. The numbers of Gal-9(+) and Tim-3(+) cells in the lungs were significantly increased, and the mRNA levels of both Gal-9 and Tim-3 in the lungs and MLNs were over-expressed in PbANKA-infected mice. In conclusion, our data suggested that Tim-3/Gal-9 may play a role in PbANKA-induced ALI.
Jinfeng
J
Liu
Siyu
S
Xiao
Shiguang
S
Huang
Fuquan
F
Pei
Fangli
F
Lu
D055371:Acute Lung Injury / Q000378:metabolism / Q000469:parasitology / Q000473:pathology*; D000818:Animals; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry; D016207:Cytokines / Q000235:genetics / Q000378:metabolism; D005260:Female; D037161:Galectins / Q000235:genetics / Q000378:metabolism*; D005786:Gene Expression Regulation; D000072597:Hepatitis A Virus Cellular Receptor 2; D007150:Immunohistochemistry; D008024:Ligands; D008168:Lung / Q000378:metabolism / Q000473:pathology*; D008198:Lymph Nodes / Q000378:metabolism / Q000473:pathology*; D008288:Malaria / Q000150:complications / Q000378:metabolism / Q000473:pathology*; D008482:Mediastinum; D051379:Mice; D018512:Parasitemia; D010962:Plasmodium berghei / Q000235:genetics; D012333:RNA, Messenger / Q000378:metabolism; D060888:Real-Time Polymerase Chain Reaction; D011991:Receptors, Virus / Q000235:genetics / Q000378:metabolism*; D013047:Specific Pathogen-Free Organisms; D015854:Up-Regulation
D016207:Cytokines; D037161:Galectins; C442241:Havcr2 protein, mouse; D000072597:Hepatitis A Virus Cellular Receptor 2; C105032:LGALS9 protein, human; D008024:Ligands; D012333:RNA, Messenger; D011991:Receptors, Virus